-
Trump vows economic boom, blames Biden in address to nation
-
Conway 120 as New Zealand in command at 216-0 against West Indies
-
Taiwan eyes fresh diplomatic ties with Honduras
-
ECB set to hold rates but debate swirls over future
-
Asian markets track Wall St lower as AI fears mount
-
EU holds crunch summit on Russian asset plan for Ukraine
-
Australia PM vows to stamp out hatred as nation mourns youngest Bondi Beach victim
-
Australian PM vows hate speech crackdown after Bondi Beach attack
-
Turkmenistan's battle against desert sand
-
Ukraine's Zelensky in Poland for first meeting with nationalist president
-
England in disarray at 59-3 in crunch Test as Lyon, Cummins pounce
-
Japan faces lawsuit over 'unconstitutional' climate inaction
-
Migrants forced to leave Canada after policy change feel 'betrayed'
-
What's next for Venezuela under the US oil blockade?
-
Salvadorans freed with conditional sentence for Bukele protest
-
Brazil Congress passes bill to cut Bolsonaro prison term
-
Cricket Australia boss slams technology 'howler' in Ashes Test
-
New Zealand 83-0 at lunch on day one of third West Indies Test
-
Ecuadorean footballer Mario Pineida shot and killed
-
US government admits liability in deadly DC air collision
-
Ex-podcaster Dan Bongino stepping down as deputy FBI director
-
Real Madrid scrape past third-tier Talavera in Spanish Cup
-
Hunt for US college mass shooter drags into fifth day
-
Cherki inspires Man City, Newcastle strike late to reach League Cup semis
-
Barcelona, Lyon and Chelsea reach Women's Champions League quarters
-
Venezuela reacts defiantly to US oil blockade, claims exports unaffected
-
Nasdaq tumbles on renewed angst over AI building boom
-
S.Africa expels Kenyans working on US Afrikaner 'refugee' applications
-
US Congress ends Syria sanctions
-
Cherki inspires Man City cruise into League Cup semis
-
Billionaire Trump nominee confirmed to lead NASA amid Moon race
-
Mahomes undergoes surgery, could return for 2026 opener: Chiefs
-
Melania Trump steps into spotlight in Amazon film trailer
-
Brazil Senate advances bill that could cut Bolsonaro jail term
-
Safonov hero as PSG beat Flamengo in Intercontinental Cup
-
Oscars to stream exclusively on YouTube from 2029
-
Oscars to stream exclusively on YouTube from 2029: Academy
-
CNN's future unclear as Trump applies pressure
-
Zelensky says Russia preparing for new 'year of war'
-
Rob Reiner's son appears in court over parents' murder
-
US Congress passes defense bill defying Trump anti-Europe rhetoric
-
Three Russia-themed anti-war films shortlisted for Oscars
-
US oil blockade of Venezuela: what we know
-
Palace boss Glasner says contract talks on hold due to hectic schedule
-
Netflix to launch FIFA World Cup video game
-
Venezuela says oil exports continue normally despite Trump 'blockade'
-
German MPs approve 50 bn euros in military purchases
-
India v South Africa 4th T20 abandoned due to fog
-
Hydrogen plays part in global warming: study
-
EU's Mercosur trade deal hits French, Italian roadblock
France warns against weight loss supplements using Garcinia plant
France warned Wednesday against dietary supplements promising weight loss that use the tropical plant Garcinia cambogia after a range of rare but serious side effects including one death were reported.
Garcinia cambogia -- which is also called Garcinia gummi-gutta or Malabar tamarind -- grows in India and Southeast Asia and has a fruit that looks like a pumpkin.
A range of supplements are sold around the world using extracts from the plant advertising its ability to suppress appetite and drive weight loss -- claims not backed by comprehensive scientific evidence.
After investigating the death of a person who took a Garcinia-based supplement -- and looking at other side effects reported in the United States and elsewhere -- French food safety agency ANSES said it "strongly advises" people against consuming the plant.
The plant has been banned from being used medicine since 2012 in France, but continues to be advertised in more 340 dietary supplements, which are mostly available online, the agency said in a statement.
There were 38 cases of serious side effects affecting the liver, pancreas, heart, muscles and mental health reported in France between 2009 and March last year, ANSES said.
These side effects can affect people with a history of psychiatric disorders, pancreatitis or hepatitis -- or who suffer from diabetes, obesity or high blood pressure, the agency added.
People taking antidepressants, antiretrovirals or drugs that affect the liver can also experience side effects.
A 71-year-old woman in France taking blood pressure drugs died of acute hepatitis in 2019 after taking Garcinia-based supplement Slim Metabol. ANSES says her death was "very likely" linked to the supplement, which remains on sale.
However people without a history of health problems can also be affected.
"A 32-year-old woman with no medical history developed myocarditis that led to her requiring a heart transplant," Aymeric Dopter, head of the ANSES nutrition risk assessment unit, told AFP.
"Some people will tell you: 'I took it and I am fine'," Dopter said.
"But we can see from these few cases that people who were simply trying to lose weight ended up with seriously impaired health -- or even died," he said.
"It is not the worth the risk."
The safety of products using Garcinia cambogia is currently being assessed by the European Food Safety Agency.
The watchdog is also investigating the risk of hydroxycitric acid, an ingredient extracted from the Garcinia plant's fruit, which is also used in supplements promoting weight loss.
France's ANSES called for the list of plants authorised for use in food supplements to be "harmonised" across the European Union.
A.Motta--PC